|
Volumn 41, Issue 5, 2002, Pages 366-370
|
Experience with oseltamivir in the control of nursing home influenza a outbreak
a a a b b a |
Author keywords
Elderly; Neuraminidase inhibitor; Prophylaxis
|
Indexed keywords
ANTIBIOTIC AGENT;
OSELTAMIVIR;
SIALIDASE INHIBITOR;
ACETAMIDE DERIVATIVE;
ANTIVIRUS AGENT;
SIALIDASE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG TOLERABILITY;
ELDERLY CARE;
ENZYME IMMUNOASSAY;
EPIDEMIC;
FEMALE;
FEVER;
GASTROINTESTINAL TOXICITY;
HUMAN;
INFECTION CONTROL;
INFLUENZA VIRUS A;
MAJOR CLINICAL STUDY;
MALE;
NURSING HOME;
PNEUMONIA;
RISK;
SYMPTOM;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
DRUG SCREENING;
ENZYME LINKED IMMUNOSORBENT ASSAY;
INFLUENZA;
ISOLATION AND PURIFICATION;
MIDDLE AGED;
SAFETY;
TREATMENT OUTCOME;
VIROLOGY;
ACETAMIDES;
AGED;
AGED, 80 AND OVER;
ANTIVIRAL AGENTS;
DISEASE OUTBREAKS;
DRUG EVALUATION;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMANS;
INFLUENZA A VIRUS;
INFLUENZA, HUMAN;
MALE;
MIDDLE AGED;
NEURAMINIDASE;
NURSING HOMES;
OSELTAMIVIR;
SAFETY;
TREATMENT OUTCOME;
|
EID: 0036019077
PISSN: 09182918
EISSN: None
Source Type: Journal
DOI: 10.2169/internalmedicine.41.366 Document Type: Article |
Times cited : (21)
|
References (20)
|